相关实验视频
Updated: May 9, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
113
对认知刺激治疗对阿尔茨海默病患者认知功能影响的元分析
Yi-Ting Lu1, Xin Zhang2, Jun Cheng3
1Department of Psychiatry, Shenyang Mental Health Center, Shenyang 110000, Liaoning Province, China.
World journal of psychiatry
|May 1, 2025
概括
认知刺激疗法 (CST) 在阿尔茨海默病 (AD) 患者中没有显著改善认知功能. 这次元分析没有发现MMSE或AD的其他认知评估对AD有统计学意义的好处.
科学领域:
- 老年学和认知神经科学
- 临床心理学和精神病学 临床心理学和精神病学
背景情况:
- 阿尔茨海默氏症 (AD) 是一个重大的全球健康挑战,没有有效的疾病修饰治疗方法.
- 目前针对阿尔茨海默病的药理干预措施成本昂贵,在逆转认知衰退方面有效性有限.
- 正在探索非药理学方法,如认知刺激疗法 (CST),以管理AD的认知功能障碍.
研究的目的:
- 评估认知刺激疗法 (CST) 在阿尔茨海默病 (AD) 患者中改善认知功能的疗效.
- 为开发改善AD管理治疗策略提供基于证据的见解.
- 评估CST在延缓认知恶化和减少患者和护理人员负担方面的潜力.
主要方法:
- 进行了一项全面的元分析,搜索多个中国和英语数据库 (CBM,万芳,VIP,CNKI) 在2010年7月21日至2022年7月21日期间发表的随机对照试验 (RCT).
- 研究侧重于CST对阿兹海默病患者认知功能的影响,遵守严格的纳入和排除标准.
- 进行了数据提取,质量评估和统计分析,使用标准化平均差异 (SMD) 与95%置信区间 (CI),包括通过漏斗图表和埃格尔测试进行灵敏度分析和出版偏差评估.
主要成果:
- 分析显示,CST并没有显著改善AD患者的精神状态检查量 (MMSE) 评分 (SMD = 0.02,95% CI: -0.37,0.42,P > 0.05).
- 对阿尔茨海默氏症认知功能评估尺度得分的分析也显示,与CST干预没有统计学上显著的差异 (SMD = -0.01,95% CI: -0.40,0.39,P > 0.05).
- 艾滋病患者的整体认知功能指标在CST后没有显著改善 (SMD = 0.01,95% CI: -0.37,0.38,P > 0.05),在研究中观察到的异质性很低.
结论:
- 认知刺激疗法 (CST) 似乎没有显著提高阿尔茨海默病 (AD) 患者的认知功能.
- 目前的证据表明,CST不会改善阿兹海默症患者的日常生活能力或减少行为症状.
- 可能需要进一步的研究来探索AD管理的替代性或辅助性非药物干预措施.
相关概念视频
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Cognitive Development During Adulthood
22
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
22
Cognitive Therapy
18
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
18

